PSMA PET/CT Findings (n = 24 Patients)
| Finding | Data |
|---|---|
| On systemic therapy at time of PSMA PET/CT | 23 (95.8%) |
| Indication for PSMA PET/CT | |
| Biochemical recurrence | 15 (62.5%) |
| Evaluation of treatment response | 9 (37.5%) |
| T+ disease | 5 (20.8%) |
| N1 disease | 13 (54.2%) |
| M1 disease | 20 (83.3%) |
| M1a only | 6 (25.0%) |
| M1b only | 12 (50.0%) |
| M1a + M1b | 1 (4.2%) |
| M1c only | 1 (4.2%) |
| Staging | |
| miT0N1M0 | 3 (12.5%) |
| miT+N1M0 | 1 (4.2%) |
| miT0N0M1a | 1 (4.2%) |
| miT+N0M1a | 1 (4.2%) |
| miT0N1M1a | 4 (16.7%) |
| miT0N0M1b | 6 (25.0%) |
| miT+N0M1b | 2 (8.3%) |
| miT0N1M1b | 4 (16.7%) |
| miT+N1M1b | 1 (4.2%) |
| miT0N0M1c | 1 (4.2%) |
Data are number.